| 2025-11-06 |
详情>>
内部人交易：
Knell Michael Gunnar股份增加2926.00股
|
| 2025-11-05 |
详情>>
股本变动：
变动后总股本4921.55万股
|
| 2025-11-05 |
详情>>
业绩披露：
2025年三季报(累计)每股收益2.66美元,归母净利润1.32亿美元,同比去年增长-41.5%
|
| 2025-11-05 |
财报披露：
美东时间 2025-11-05 盘前发布财报
|
| 2025-08-06 |
详情>>
业绩披露：
2025年中报每股收益1.56美元,归母净利润7779.50万美元,同比去年增长-50.55%
|
| 2025-05-07 |
详情>>
业绩披露：
2025年一季报每股收益0.50美元,归母净利润2546.90万美元,同比去年增长-62.17%
|
| 2025-04-02 |
股东大会：
将于2025-05-20召开股东大会
会议内容 ▼▲
- 1.To elect each of the eleven persons named in this Proxy Statement to our Board of Directors to hold office until the next Annual Meeting of Shareholders.
2.To approve an advisory vote on our executive compensation.
3.To consider and act upon a proposal to ratify the appointment of PricewaterhouseCoopers LLP as our independent registered public accounting firm for the fiscal year ending December 27, 2025.
4.To vote on a shareholder proposal described in this Proxy Statement, if properly presented at the Annual Meeting.
5.To transact such other business as may be properly brought before the Annual Meeting and any adjournments thereof.
|
| 2025-02-19 |
详情>>
业绩披露：
2024年年报每股收益0.20美元,归母净利润1029.70万美元,同比去年增长-97.83%
|
| 2025-02-19 |
详情>>
业绩披露：
2022年年报每股收益9.57美元,归母净利润4.86亿美元,同比去年增长24.36%
|
| 2024-11-06 |
详情>>
业绩披露：
2024年三季报(累计)每股收益4.39美元,归母净利润2.26亿美元,同比去年增长-21.4%
|
| 2024-08-07 |
详情>>
业绩披露：
2024年中报每股收益3.06美元,归母净利润1.57亿美元,同比去年增长-21.4%
|
| 2024-08-07 |
详情>>
业绩披露：
2023年中报每股收益3.91美元,归母净利润2.00亿美元,同比去年增长-1.08%
|
| 2024-05-09 |
详情>>
业绩披露：
2024年一季报每股收益1.31美元,归母净利润6732.90万美元,同比去年增长-34.72%
|
| 2024-03-29 |
股东大会：
将于2024-05-08召开股东大会
会议内容 ▼▲
- 1.To elect each of the eleven (11) persons named in this Proxy Statement to our Board of Directors to hold office until the next Annual Meeting of Shareholders.
2.To approve an advisory vote on our executive compensation.
3.To consider and act upon a proposal to ratify the appointment of PricewaterhouseCoopers LLP as our independent registered public accounting firm for the fiscal year ending December 28, 2024.
4.To vote on a shareholder proposal described in this Proxy Statement, if properly presented at the Annual Meeting.
5.To transact such other business as may be properly brought before the Annual Meeting and any adjournments thereof.
|
| 2024-02-14 |
详情>>
业绩披露：
2023年年报每股收益9.27美元,归母净利润4.75亿美元,同比去年增长-2.39%
|
| 2023-11-08 |
详情>>
业绩披露：
2023年三季报(累计)每股收益5.62美元,归母净利润2.88亿美元,同比去年增长-3.77%
|
| 2023-03-30 |
股东大会：
将于2023-05-09召开股东大会
会议内容 ▼▲
- 1.To elect each of the eleven (11) persons named in this Proxy Statement to our Board of Directors to hold office until the next Annual Meeting of Shareholders.
2.To approve an advisory vote on our executive compensation.
3.To hold an advisory vote on the frequency of future advisory votes on executive compensation
4.To consider and act upon a proposal to ratify the appointment of PricewaterhouseCoopers LLP as our independent registered public accounting firm for the fiscal year ending December 30, 2023.
5.To vote on a shareholder proposal described in this Proxy Statement, if properly presented at the Annual Meeting.
6.To transact such other business as may be properly brought before the Annual Meeting and any adjournments thereof.
|
| 2022-11-30 |
复牌提示：
2022-11-30 09:55:31 停牌，复牌日期 2022-11-30 10:28:30
|
| 2022-03-30 |
股东大会：
将于2022-05-10召开股东大会
会议内容 ▼▲
- 1.To elect the ten (10) persons named in this Proxy Statement to our Board of Directors to hold office until the next Annual Meeting of Shareholders.
2.To approve an advisory vote on our executive compensation.
3.To consider and act upon a proposal to ratify the appointment of PricewaterhouseCoopers LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2022.
4.To transact such other business as may be properly brought before the Annual Meeting and any adjournments thereof.
|
| 2021-09-06 |
温馨提示：
美股因劳工节，9月6日休市一天
|
| 2021-03-26 |
股东大会：
将于2021-05-06召开股东大会
会议内容 ▼▲
- 1.To elect the eleven (11) persons named in this Proxy Statement to our Board of Directors to hold office until the next Annual Meeting of Shareholders.
2.To approve an advisory vote on our executive compensation.
3.To consider and act upon a proposal to ratify the appointment of PricewaterhouseCoopers LLP as our independent registered public accounting firm for the fiscal year ending December 25, 2021.
4.To transact such other business as may be properly brought before the Annual Meeting and any adjournments thereof.
|
| 2020-03-26 |
股东大会：
将于2020-05-06召开股东大会
会议内容 ▼▲
- 1.To elect the eleven (11) persons named in this Proxy Statement to our Board of Directors to hold office until the next Annual Meeting of Shareholders.
2.To approve an advisory vote on our executive compensation.
3.To approve an amendment to the Charles River Laboratories International, Inc. 2018 Incentive Plan to (A) increase the number of shares of common stock for issuance thereunder by 1,750,000 from 7,198,598 to 8,948,598 and (B) to increase the maximum term of stock options and stock appreciation rights from seven years to ten years.
4.To consider and act upon a proposal to ratify the appointment of PricewaterhouseCoopers LLP as our independent registered public accounting firm for the fiscal year ending December 26, 2020.
5.To transact such other business as may be properly brought before the Annual Meeting and any adjournments thereof.
|
| 2019-04-04 |
股东大会：
将于2019-05-21召开股东大会
会议内容 ▼▲
- 1.To elect the ten (10) persons named in this Proxy Statement to our Board of Directors to hold office until the next Annual Meeting of Shareholders.
2.To approve an advisory vote on our executive compensation.
3.To consider and act upon a proposal to ratify the appointment of PricewaterhouseCoopers LLP as our independent registered public accounting firm for the fiscal year ending December 28, 2019.
4.To transact such other business as may be properly brought before the Annual Meeting and any adjournments thereof.
|
| 2018-03-29 |
股东大会：
将于2018-05-08召开股东大会
会议内容 ▼▲
- 1.To elect the eleven (11) persons named in this Proxy Statement to our Board of Directors to hold office until the next Annual Meeting of Shareholders.
2.To approve an advisory vote on our executive compensation.
3.To approve the Charles River Laboratories International, Inc. 2018 Incentive Plan.
4.To consider and act upon a proposal to ratify the appointment of PricewaterhouseCoopers LLP as our independent registered public accounting firm for the fiscal year ending December 29, 2018.
5.To transact such other business as may be properly brought before the Annual Meeting and any adjournments thereof.
|
| 2017-03-30 |
股东大会：
将于2017-05-09召开股东大会
会议内容 ▼▲
- 1.To elect the nine (9) persons named in this Proxy Statement to our Board of Directors to hold office until the next Annual Meeting of Shareholders.
2.To approve an advisory vote on our executive compensation.
3.To hold an advisory vote on the frequency of future advisory votes on executive compensation.
4.To approve the Charles River Laboratories International, Inc. Incentive Compensation Plan.
5.To consider and act upon a proposal to ratify the appointment of PricewaterhouseCoopers LLP as our independent registered public accounting firm for the fiscal year ending December 30, 2017.
6.To vote on a shareholder proposal described in this Proxy Statement if properly presented at this meeting.
7.To transact such other business as may be properly brought before the Annual Meeting and any adjournments thereof.
|
| 2016-03-31 |
股东大会：
将于2016-05-11召开股东大会
会议内容 ▼▲
- 1.To elect the nine (9) persons named in this Proxy Statement to our Board of Directors to hold office until the next Annual Meeting of Shareholders.
2.To approve an advisory resolution on our executive compensation.
3.To approve the Charles River Laboratories International, Inc. 2016 Incentive Plan.
4.To consider and act upon a proposal to ratify the appointment of PricewaterhouseCoopers LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2016.
5.To transact such other business as may be properly brought before the Annual Meeting and any adjournments thereof.
|